Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216).
      QxMD      Google Scholar   
Citation:
JAMA Oncol vol 8 (5) 717-728
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
11
Parents:
3603  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UG1CA233180, UG1CA233247, UG1CA233253, UG1CA233339, R01CA172253, UG1CA189873, U10CA180820 and UG1CA233247 (ECOG-ACRIN)  
Corr. Author:
 
Authors:
                                   
Networks:
BAPTIST, CORA, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-TN008   
Study
Alliance-A151216
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
N/A
Keywords:
Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Chemotherapy, Adjuvant, Cisplatin, Cohort Studies, Female, Humans, Lung Neoplasms, Neoplasm Staging, Retrospective Studies